van Asperen CJ - Search Results

1

Rare variants in XRCC2 as breast cancer susceptibility alleles.

Hilbers FS, Wijnen JT, Hoogerbrugge N, Oosterwijk JC, Collee MJ, Peterlongo P, Radice P, Manoukian S, Feroce I, Capra F, Couch FJ, Wang X, Guidugli L, Offit K, Shah S, Campbell IG, Thompson ER, James PA, Trainer AH, Gracia J, Benitez J, van Asperen CJ, Devilee P. Hilbers FS, et al. Among authors: van asperen cj. J Med Genet. 2012 Oct;49(10):618-20. doi: 10.1136/jmedgenet-2012-101191. J Med Genet. 2012. PMID: 23054243

2

A distinct phenotype characterizes tumors from a putative genetic trait involving chondrosarcoma and breast cancer occurring in the same patient.

Cleton-Jansen AM, Timmerman MC, van de Vijver MJ, van Asperen CJ, Kroon HM, Eilers PH, Hogendoorn PC. Cleton-Jansen AM, et al. Among authors: van asperen cj, van de vijver mj. Lab Invest. 2004 Feb;84(2):191-202. doi: 10.1038/labinvest.3700032. Lab Invest. 2004. PMID: 14661035 Free article.

3

The CHEK2*1100delC variant acts as a breast cancer risk modifier in non-BRCA1/BRCA2 multiple-case families.

Oldenburg RA, Kroeze-Jansema K, Kraan J, Morreau H, Klijn JG, Hoogerbrugge N, Ligtenberg MJ, van Asperen CJ, Vasen HF, Meijers C, Meijers-Heijboer H, de Bock TH, Cornelisse CJ, Devilee P. Oldenburg RA, et al. Among authors: van asperen cj. Cancer Res. 2003 Dec 1;63(23):8153-7. Cancer Res. 2003. PMID: 14678969

4

Feeling at risk: how women interpret their familial breast cancer risk.

van Dijk S, Otten W, van Asperen CJ, Timmermans DR, Tibben A, Zoeteweij MW, Silberg S, Breuning MH, Kievit J. van Dijk S, et al. Among authors: van asperen cj. Am J Med Genet A. 2004 Nov 15;131(1):42-9. doi: 10.1002/ajmg.a.30322. Am J Med Genet A. 2004. PMID: 15382029

5

Unclassified variants in disease-causing genes: nonuniformity of genetic testing and counselling, a proposal for guidelines.

Vink GR, van Asperen CJ, Devilee P, Breuning MH, Bakker E. Vink GR, et al. Among authors: van asperen cj. Eur J Hum Genet. 2005 May;13(5):525-7. doi: 10.1038/sj.ejhg.5201379. Eur J Hum Genet. 2005. PMID: 15741995 No abstract available.

6

Homozygosity for a CHEK2*1100delC mutation identified in familial colorectal cancer does not lead to a severe clinical phenotype.

van Puijenbroek M, van Asperen CJ, van Mil A, Devilee P, van Wezel T, Morreau H. van Puijenbroek M, et al. Among authors: van asperen cj, van mil a, van wezel t. J Pathol. 2005 Jun;206(2):198-204. doi: 10.1002/path.1764. J Pathol. 2005. PMID: 15818573

7

What's the message? Interpretation of an uninformative BRCA1/2 test result for women at risk of familial breast cancer.

van Dijk S, Otten W, Timmermans DR, van Asperen CJ, Meijers-Heijboer H, Tibben A, Breuning MH, Kievit J. van Dijk S, et al. Among authors: van asperen cj. Genet Med. 2005 Apr;7(4):239-45. doi: 10.1097/01.gim.0000159902.34833.26. Genet Med. 2005. PMID: 15834241 Free article.

8

A genome wide linkage search for breast cancer susceptibility genes.

Smith P, McGuffog L, Easton DF, Mann GJ, Pupo GM, Newman B, Chenevix-Trench G; kConFab Investigators; Szabo C, Southey M, Renard H, Odefrey F, Lynch H, Stoppa-Lyonnet D, Couch F, Hopper JL, Giles GG, McCredie MR, Buys S, Andrulis I, Senie R; BCFS, BRCAX Collaborators Group; Goldgar DE, Oldenburg R, Kroeze-Jansema K, Kraan J, Meijers-Heijboer H, Klijn JG, van Asperen C, van Leeuwen I, Vasen HF, Cornelisse CJ, Devilee P, Baskcomb L, Seal S, Barfoot R, Mangion J, Hall A, Edkins S, Rapley E, Wooster R, Chang-Claude J, Eccles D, Evans DG, Futreal P, Nathanson KL, Weber BL; Breast Cancer Susceptibility Collaboration (UK); Rahman N, Stratton MR. Smith P, et al. Among authors: van leeuwen i, van asperen c. Genes Chromosomes Cancer. 2006 Jul;45(7):646-55. doi: 10.1002/gcc.20330. Genes Chromosomes Cancer. 2006. PMID: 16575876 Free PMC article.

9

Clinical characteristics affect the impact of an uninformative DNA test result: the course of worry and distress experienced by women who apply for genetic testing for breast cancer.

van Dijk S, Timmermans DR, Meijers-Heijboer H, Tibben A, van Asperen CJ, Otten W. van Dijk S, et al. Among authors: van asperen cj. J Clin Oncol. 2006 Aug 1;24(22):3672-7. doi: 10.1200/JCO.2005.03.7259. J Clin Oncol. 2006. PMID: 16877736

10

Prediction of BRCA1/2 mutation status in patients with ovarian cancer from a hospital-based cohort.

Jacobi CE, van Ierland Y, van Asperen CJ, Hallensleben E, Devilee P, Jan Fleuren G, Kenter GG. Jacobi CE, et al. Among authors: van asperen cj, van ierland y. Genet Med. 2007 Mar;9(3):173-9. doi: 10.1097/GIM.0b013e318032e4ab. Genet Med. 2007. PMID: 17413421 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

220 results

Search Page